Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum

Ji Hyun Park, Sook in Ryu, Il Hwan Kim

Research output: Contribution to journalArticle

Abstract

Xanthelasma palpebrarum (XP) does not regress spontaneously and most patients complain of cosmetic discomfort. This study presents the results of treatment of XP using 1,444 nm Nd:YAG laser. We aim to evaluate the clinical efficacy of a 1,444 nm Nd:YAG laser in XP. Twenty-eight patients with XP treated with 1,444 nm Nd:YAG laser were analyzed retrospectively. A physician scored the results based on the reduction of the initial lesion area under six categories. The results were scored as follows: no effect (0% clearing of xanthelasma area), some response (1–24% clearing), moderate response (25–49% clearing), marked response (50–74% clearing), satisfactory result (75-99% clearing), and excellent result (100% clearing). Twelve patients (42.8%) showed excellent clearance and 10 patients (35.7%) had clearance greater than 75%. Overall, 24 patients (85.7%) showed improvement higher than 50%. Half of the patients (14 patients) ended the treatment with satisfactory results with one treatment session. Including seven patients who ended the treatment after two laser sessions, 21 patients (75%) reported satisfactory results and ended the treatment after 1 to 2 laser sessions. XP treatment with 1,444 nm Nd:YAG laser showed promising results. We believe it can be an effective and safe treatment modality for XP.

Original languageEnglish
Pages (from-to)141-145
Number of pages5
JournalJournal of Cosmetic and Laser Therapy
Volume22
Issue number3
DOIs
Publication statusPublished - 2020 Apr 2

Keywords

  • 1,444 nm Nd:YAG laser
  • Xanthelasma palpebrarum
  • laser treatment

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Fingerprint Dive into the research topics of 'Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum'. Together they form a unique fingerprint.

  • Cite this